Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FL1V6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $16,249.95 for Stelara 90 mg/ml syringes, with an ultimate completion date of September 18, 2025. The award, issued on August 27, 2025, carries firm fixed-price terms and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies for military healthcare facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering an extensive range of medications, biologics, and medical consumables. The company's expertise in distributing branded and generic prescription drugs, specialty medications, and biologics to Department of Defense healthcare sites positions it as a key vendor for supporting military medical readiness. The current award for Stelara, a specialty pharmaceutical used in dermatological and rheumatological treatments, represents one of many pharmaceutical deliveries the contractor provides to federal healthcare systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FL1V6?
SPE2DB25FL1V6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FL1V6 worth?
The government has obligated $16,250 on SPE2DB25FL1V6.
Is contract SPE2DB25FL1V6 an order under another contract?
Yes. SPE2DB25FL1V6 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1V6 competed?
The extent of competition for SPE2DB25FL1V6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award